XML 32 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 17,683 $ 172,436,176 $ (3,669) $ (166,170,020) $ 6,280,170
Balance, Shares at Dec. 31, 2018 17,682,839        
Issuance of common stock pursuant to FBR At Market Issuance Sales Agreement $ 446 $ 522,137 $ 522,583
Issuance of common stock pursuant to FBR At Market Issuance Sales Agreement, shares 446,369        
Issuance costs associated with FBR At Market Issuance Sales Agreement, shares   (19,382)     (19,382)
Issuance of restricted common stock to vendors $ 60 $ 57,540     $ 57,600
Issuance of restricted common stock to vendors, shares 60,000        
Share-based compensation expense   79,573     79,573
Foreign currency translation adjustment     649   649
Net loss       (1,639,627) (1,639,627)
Balance at Mar. 31, 2019 $ 18,189 173,076,044 (3,020) (167,809,647) 5,281,566
Balance, Shares at Mar. 31, 2019 18,189,208        
Balance at Dec. 31, 2019 $ 21,753 177,006,004 (45,010) (175,525,612) 1,457,135
Balance, Shares at Dec. 31, 2019 21,753,124        
Issuance of common stock in public financing, net of underwriting discount         78,338
Issuance of common stock pursuant to FBR At Market Issuance Sales Agreement $ 1,732 3,987,494 3,989,226
Issuance of common stock pursuant to FBR At Market Issuance Sales Agreement, shares 1,732,115        
Issuance costs associated with FBR At Market Issuance Sales Agreement   (174,721) (174,721)
Issuance of common stock for milestone $ 1,956 4,998,044 5,000,000
Issuance of common stock for milestone, shares 1,956,182        
Issuance of restricted common stock to vendors $ 30 58,970 59,000
Issuance of restricted common stock to vendors, shares 30,000        
Exercise of common stock options $ 2 2
Exercise of common stock options, Shares 2,189        
Exercise of warrants $ 305 685,079     685,384
Exercise of warrants, shares 304,821        
Share-based compensation expense 63,691 63,691
Foreign currency translation adjustment 16,243 16,243
Net loss (7,581,334) (7,581,334)
Balance at Mar. 31, 2020 $ 25,778 $ 186,624,561 $ (28,767) $ (183,106,946) $ 3,514,626
Balance, Shares at Mar. 31, 2020 25,778,431